These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6537079)

  • 1. Prostatic cancer: the case for surveillance.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):267-72. PubMed ID: 6537079
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer therapy: a recipe for confusion.
    See W
    Iowa Med; 1994 Jun; 84(6):255-8. PubMed ID: 7520030
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():703-8. PubMed ID: 11037488
    [No Abstract]   [Full Text] [Related]  

  • 4. Glandular profiles and cellular patterns in prostatic cancer grading. National Prostatic Cancer Project System.
    Gaeta JF
    Urology; 1981 Mar; 17(Suppl 3):33-7. PubMed ID: 7210369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Left supraclavicular adenopathy with a neuroendocrine pattern of unknown cause: prostatic carcinoma metastasis].
    Fernández Borrell A; Peinado Ibarra F; Gómez Sancha F; Teba del Pino F; Minguez Martínez R; Morato Robert P; Arellano Gañan R; Romero Tejada JC; Pereira Sanz I
    Actas Urol Esp; 1999; 23(7):603-8. PubMed ID: 10488615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
    Walsh PC
    J Urol; 2005 Sep; 174(3):929. PubMed ID: 16093992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphology and morphogenesis of prostatic small cell cancer].
    Heine M; Lessmeister E
    Pathologe; 1985 Nov; 6(6):323-6. PubMed ID: 3003724
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic cancer: prognostic criteria.
    Chisholm GD
    Turk J Pediatr; 1984; 26(1-4):265-6. PubMed ID: 6399422
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of common PCA (acinar adenocarcinoma). German Society of Urology].
    Urologe A; 1999 Nov; 38(6):632-39. PubMed ID: 10691579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of prognostic factors in prostate cancer].
    Schubert J; Kowalik S
    Z Arztl Fortbild (Jena); 1993 Jul; 87(7):593-7. PubMed ID: 8362544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Place of surveillance in the treatment of localized prostate cancer].
    Ravery V; Boccon-Gibod L
    Prog Urol; 1999 Apr; 9(2):225-30; discussion 229-30. PubMed ID: 10370945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer.
    Schlegel PN
    Curr Ther Endocrinol Metab; 1994; 5():543-50. PubMed ID: 7535663
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostate cancer in 1994].
    Gil-Vernet JM; Gil-Vernet Sedó JM
    Arch Esp Urol; 1994 May; 47(4):315-35. PubMed ID: 8053718
    [No Abstract]   [Full Text] [Related]  

  • 15. Parameters of response and progression in prostate cancer.
    Newling DW
    Prog Clin Biol Res; 1990; 359():25-48; discussion 73-4. PubMed ID: 2284296
    [No Abstract]   [Full Text] [Related]  

  • 16. Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
    Veltri RW; Khan MA; Miller MC; Epstein JI; Mangold LA; Walsh PC; Partin AW
    Clin Cancer Res; 2004 May; 10(10):3465-73. PubMed ID: 15161703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
    Ercole B; Marietti SR; Fine J; Albertsen PC
    J Urol; 2008 Oct; 180(4):1336-9; discussion 1340-1. PubMed ID: 18707696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Aus G
    Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial therapy of advanced prostate cancer.
    Ismail M; Gomella LG
    Compr Ther; 1997 Oct; 23(10):649-55. PubMed ID: 9327180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.